Thrombin enhances soluble Fms-like tyrosine kinase 1 expression in trophoblasts; Possible involvement in the pathogenesis of preeclampsia

Fertility and Sterility

Volumn 98, Issue 4, 2012, Pages 917-921

  Zhao, Yin ^a   Koga, Kaori ^a   Osuga, Yutaka ^a   Nagai, Miwako ^a   Izumi, Gentaro ^a   Takamura, Masashi ^a   Harada, Miyuki ^a   Hirota, Yasushi ^a   Yoshino, Osamu ^a   Taketani, Yuji ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

preeclampsia; protease activated receptor 1 (PAR 1); Soluble Fms like tyrosine kinase 1 (sFlt 1); thrombin; trophoblasts

Indexed keywords

MESSENGER RNA; PLACENTAL GROWTH FACTOR; PROTEINASE ACTIVATED RECEPTOR 1; THROMBIN; THROMBIN INHIBITOR; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1;

ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN TISSUE; PATHOGENESIS; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; REAL TIME POLYMERASE CHAIN REACTION; TROPHOBLAST;

AMINO ACID CHLOROMETHYL KETONES; CELL LINE; FEMALE; GENE EXPRESSION; HEMOSTATICS; HUMANS; PEPTIDE FRAGMENTS; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY PROTEINS; RECEPTOR, PAR-1; RECEPTORS, THROMBIN; THROMBIN; TROPHOBLASTS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 84866995940     PISSN: 00150282     EISSN: 15565653     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2012.06.038     Document Type: Article

References (38)

1. J.J. Walker Pre-eclampsia Lancet 356 2000 1260 1265
2. World Health Organization The world health report 2005: make every mother and child count 2005 WHO Geneva 63
3. E. Shibata, A. Rajakumar, R.W. Powers, R.W. Larkin, C. Gilmour, and L.M. Bodnar Soluble fms-like tyrosine kinase 1 is increased in preeclampsia but not in normotensive pregnancies with small-for-gestational-age neonates: relationship to circulating placental growth factor J Clin Endocrinol Metab 90 2005 4895 4903
4. E.D. Dimitrakova, J.D. Dimitrakov, S.A. Karumanchi, B.K. Pehlivanov, N.P. Milchev, and D.I. Dimitrakov Placental soluble Fms-like tyrosine-kinase-1 (sFlt-1) in pregnant women with preeclampsia Folia Med (Plovdiv) 46 2004 19 21
5. S.A. Karumanchi, and Y. Bdolah Hypoxia and sFlt-1 in preeclampsia: the "chicken-and-egg" question Endocrinology 145 2004 4835 4837
6. S.E. Maynard, J.Y. Min, J. Merchan, K.H. Lim, J. Li, and S. Mondal Excess placental soluble Fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia J Clin Invest 111 2003 649 658
7. F. Lu, M. Longo, E. Tamayo, W. Maner, A. Al-Hendy, and G.D. Anderson The effect of over-expression of sFlt-1 on blood pressure and the occurrence of other manifestations of preeclampsia in unrestrained conscious pregnant mice Am J Obstet Gynecol 196 2007 396.e1 396.e7 discussion e7
8. H. Stepan, W. Schaarschmidt, A. Jank, S. Verlohren, and J. Kratzsch [Use of angiogenic factors (sFlt-1/PlGF ratio) to confirm the diagnosis of preeclampsia in clinical routine: first experience] Z Geburtshilfe Neonatol 214 2010 234 238 In German
9. Q. Zhou, F.Y. Qiao, C. Zhao, and H.Y. Liu Hypoxic trophoblast-derived sFlt-1 may contribute to endothelial dysfunction: implication for the mechanism of trophoblast-endothelial dysfunction in preeclampsia Cell Biol Int 35 2011 61 66
10. C.W. Park, J.S. Park, S.S. Shim, J.K. Jun, B.H. Yoon, and R. Romero An elevated maternal plasma, but not amniotic fluid, soluble fms-like tyrosine kinase-1 (sFlt-1) at the time of mid-trimester genetic amniocentesis is a risk factor for preeclampsia Am J Obstet Gynecol 193 2005 984 989
11. G.C. McKeeman, J.E. Ardill, C.M. Caldwell, A.J. Hunter, and N. McClure Soluble vascular endothelial growth factor receptor-1 (sFlt-1) is increased throughout gestation in patients who have preeclampsia develop Am J Obstet Gynecol 191 2004 1240 1246
12. K. Koga, Y. Osuga, T. Tajima, Y. Hirota, T. Igarashi, and T. Fujii Elevated serum soluble Fms-like tyrosine kinase 1 (sFlt1) level in women with hydatidiform mole Fertil Steril 94 2010 305 308
13. T. Nagamatsu, T. Fujii, M. Kusumi, L. Zou, T. Yamashita, and Y. Osuga Cytotrophoblasts up-regulate soluble Fms-like tyrosine kinase-1 expression under reduced oxygen: an implication for the placental vascular development and the pathophysiology of preeclampsia Endocrinology 145 2004 4838 4845
14. C.C. Zhou, S. Ahmad, T. Mi, S. Abbasi, L. Xia, and M.C. Day Autoantibody from women with preeclampsia induces soluble Fms-like tyrosine kinase-1 production via angiotensin type 1 receptor and calcineurin/nuclear factor of activated T-cells signaling Hypertension 51 2008 1010 1019
15. S. Zhao, Y. Gu, R. Fan, L.J. Groome, D. Cooper, and Y. Wang Proteases and sFlt-1 release in the human placenta Placenta 31 2010 512 518
16. E. Page The relation between hydatid moles, relative ischemia of the gravid uterus, and the placenvtal origin of eclampsia Am J Obstet Gynecol 37 1938 291 293
17. M. Jacobs, N. Nassar, C.L. Roberts, R. Hadfield, J.M. Morris, and A.W. Ashton Levels of soluble Fms-like tyrosine kinase one in first trimester and outcomes of pregnancy: a systematic review Reprod Biol Endocrinol 9 2011 77
18. M.P. de Maat, M.W. Jansen, E.T. Hille, H.L. Vos, K.W. Bloemenkamp, and S. Buitendijk Preeclampsia and its interaction with common variants in thrombophilia genes J Thromb Haemost 2 2004 1588 1593
19. C. Bosco, M. Parra, P. Barja, R. Rodrigo, V. Fernandez, and M. Suarez Increased immunohistochemical expression of thrombomodulin at placental perivascular myofibroblast in severe preeclampsia (PE) Histol Histopathol 20 2005 1045 1055
20. C.J. Lockwood, P. Toti, F. Arcuri, E. Norwitz, E.F. Funai, and S.T. Huang Thrombin regulates soluble Fms-like tyrosine kinase-1 (sFlt-1) expression in first trimester decidua: implications for preeclampsia Am J Pathol 170 2007 1398 1405
21. R. Uxa, D. Baczyk, J.C. Kingdom, S. Viero, R. Casper, and S. Keating Genetic polymorphisms in the fibrinolytic system of placentas with massive perivillous fibrin deposition Placenta 31 2010 499 505
22. L. Heilmann, W. Rath, and K. Pollow Hemostatic abnormalities in patients with severe preeclampsia Clin Appl Thromb Hemost 13 2007 285 291
23. H. Fox Pathology of placenta. Major problems in pathology Vol. 7 1978 Saunders Philadelphia
24. J.L. Weiss, F.D. Malone, J. Vidaver, R.H. Ball, D.A. Nyberg, and C.H. Comstock Threatened abortion: a risk factor for poor pregnancy outcome, a population-based screening study Am J Obstet Gynecol 190 2004 745 750
25. M. Zygmunt, F. Herr, K. Munstedt, U. Lang, and O.D. Liang Angiogenesis and vasculogenesis in pregnancy Eur J Obstet Gynecol Reprod Biol 110 Suppl 1 2003 S10 S18
26. B. Brenner Thrombophilia and fetal loss Semin Thromb Hemost 29 2003 165 170
27. M. Kupferminc, E. Rimon, A. Many, S. Maslovitz, J.B. Lessing, and R. Gamzu Low molecular weight heparin versus no treatment in women with previous severe pregnancy complications and placental findings without thrombophilia Blood Coagul Fibrinolysis 22 2011 123 126
28. C.H. Graham, T.S. Hawley, R.G. Hawley, J.R. MacDougall, R.S. Kerbel, and N. Khoo Establishment and characterization of first trimester human trophoblast cells with extended lifespan Exp Cell Res 206 1993 204 211
29. Y. Hirota, Y. Osuga, O. Yoshino, K. Koga, T. Yano, and T. Hirata Possible roles of thrombin-induced activation of protease-activated receptor 1 in human luteinized granulosa cells J Clin Endocrinol Metab 88 2003 3952 3957
30. Y. Hirota, Y. Osuga, T. Hirata, O. Yoshino, K. Koga, and M. Harada Possible involvement of thrombin/protease-activated receptor 1 system in the pathogenesis of endometriosis J Clin Endocrinol Metab 90 2005 3673 3679
31. S.C. Even-Ram, S. Grisaru-Granovsky, D. Pruss, M. Maoz, Z. Salah, and Y. Yong-Jun The pattern of expression of protease-activated receptors (PARs) during early trophoblast development J Pathol 200 2003 47 52
32. P.J. O'Brien, H. Koi, S. Parry, L.F. Brass, J.F. Strauss 3rd, and L.P. Wang Thrombin receptors and protease-activated receptor-2 in human placentation: receptor activation mediates extravillous trophoblast invasion in vitro Am J Pathol 163 2003 1245 1254
33. T. Arisato, K.P. Sarker, K. Kawahara, M. Nakata, T. Hashiguchi, and M. Osame The agonist of the protease-activated receptor-1 (PAR) but not PAR3 mimics thrombin-induced vascular endothelial growth factor release in human smooth muscle cells Cell Mol Life Sci 60 2003 1716 1724
34. Z.M. Bian, S.G. Elner, and V.M. Elner Thrombin-induced VEGF expression in human retinal pigment epithelial cells Invest Ophthalmol Vis Sci 48 2007 2738 2746
35. J. Liu, P. Schuff-Werner, and M. Steiner Thrombin/thrombin receptor (PAR-1)-mediated induction of IL-8 and VEGF expression in prostate cancer cells Biochem Biophys Res Commun 343 2006 183 189
36. S. Nagy, M. Bush, J. Stone, R.H. Lapinski, and S. Gardo Clinical significance of subchorionic and retroplacental hematomas detected in the first trimester of pregnancy Obstet Gynecol 102 2003 94 100
37. B. Al-Ani, P.W. Hewett, M.J. Cudmore, T. Fujisawa, M. Saifeddine, and H. Williams Activation of proteinase-activated receptor 2 stimulates soluble vascular endothelial growth factor receptor 1 release via epidermal growth factor receptor transactivation in endothelial cells Hypertension 55 2010 689 697
38. O. Erez, R. Romero, S.S. Kim, J.S. Kim, Y.M. Kim, and D.E. Wildman Over-expression of the thrombin receptor (PAR-1) in the placenta in preeclampsia: a mechanism for the intersection of coagulation and inflammation J Matern Fetal Neonatal Med 21 2008 345 355